A trial-based approach to statin guidelines

JAMA

Volumn 310, Issue 11, 2013, Pages 1123-1124

  Ridker, Paul M ^a   Wilson, Peter W F ^b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b EMORY UNIVERSITY   (United States)

^c ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; EZETIMIBE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; SIMVASTATIN;

CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CONGESTIVE HEART FAILURE; CORONARY ARTERY CALCIFICATION; DRUG EFFICACY; HIGH RISK PATIENT; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; MONOTHERAPY; PATIENT CARE; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; RISK REDUCTION; SECONDARY PREVENTION; SHORT SURVEY;

EID: 84884190315     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.276529     Document Type: Short Survey

References (7)

1. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110(2):227-239. (Pubitemid 38924592)
2. Hlatky MA, Greenland P, Arnett DK, et al. Criteria for evaluation of novel markers of cardiovascular risk. Circulation. 2009;119(17):2408-2416.
3. Gibbons GH, Shurin SB, Mensah GA, Lauer MS. Refocusing the agenda on cardiovascular guidelines: an announcement from the National Heart, Lung, and Blood Institute [published online June 19, 2013]. Circulation. doi:10.1161/CIRCULATIONAHA.113.004587.
4. Ridker PM. What works and in whom? a simple, easily applied, evidence-based approach to guidelines for statin therapy. Circ Cardiovasc Qual Outcomes. 2012;5(4):592-593.
5. Mihaylova B, Emberson J, Blackwell L, et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012;380(9841):581-590.
6. Rajpathak SN, Kumbhani DJ, Crandall J, et al. Statin therapy and risk of developing type 2 diabetes: ameta-analysis. Diabetes Care. 2009;32(10):1924- 1929.
7. Preiss D, Seshasai SR, Welsh P, et al. Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. JAMA. 2011;305(24):2556-2564.